Literature DB >> 6174547

Studies of the function of natural killer-interferon system in patients with Sjögren syndrome.

N Minato, A Takeda, S Kano, F Takaku.   

Abstract

The natural killer (NK)-interferon (IFN) system is shown to be significantly involved in the resistance of host to viral infections and to tumours in numbers of animal models (1-4). The patients with Sjögren syndrome (SS) as well as those with collagen diseases were systematically investigated for the functions of NK-IFN system, including endogenous and augmented NK activity, IFN production, and responsiveness of NK cells to IFN stimulation, using virus persistently infected cells (heLa-measles cells) as target and stimulator cells. Although endogenous NK activity was not reduced, augmented NK activity by HeLa-measles cells in vitro was significantly depressed in patients with SS compared with that in age-matched normal controls. The patients with SS had also impaired capacity to produce IFN, which is shown to be a major factor regulating NK activity (5,6) in response to HeLa-measles cells in vitro. In three patients with SS who showed severely depressed NK activity, the effect of exogenous IFN was examined, and virtually no augmentation of NK activity was observed in all cases. Under the same condition, the normal controls demonstrated a dramatic increase in NK activity. The reduced IFN production was observed in all examined patients with SS, whereas impaired augmentation of NK activity by the stimulation with HeLa-measles cells as well as IFN seemed to be more striking in patients with the systemic manifestations of the disease, such as hypergammaglobulinemia and lymphoid hyperplasia. The possible involvement of dysfunction of NK-IFN system in the systemic manifestations of SS is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174547      PMCID: PMC371014          DOI: 10.1172/jci110484

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  The Chediak-Higashi syndrome.

Authors:  A R PAGE; H BERENDES; J WARNER; R A GOOD
Journal:  Blood       Date:  1962-09       Impact factor: 22.113

2.  Natural killer cell activity in systemic lupus erythematosus.

Authors:  K Oshimi; M Sumiya; N Gonda; S Kano; F Takaku
Journal:  Lancet       Date:  1979-11-10       Impact factor: 79.321

3.  Virus-like structure in Sjögren's syndrome.

Authors:  M A Shearn; W H Tu; B G Stephens; J C Lee
Journal:  Lancet       Date:  1970-03-14       Impact factor: 79.321

4.  The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome.

Authors:  L G Anderson; N Talal
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

5.  Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo.

Authors:  O Haller; M Hansson; R Kiessling; H Wigzell
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

6.  Impaired Lymphocyte Transformation and Delayed Hypersensitivity in Sjögren's Syndrome.

Authors:  B G Leventhal; D S Waldorf; N Talal
Journal:  J Clin Invest       Date:  1967-08       Impact factor: 14.808

7.  Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice.

Authors:  L M Reid; N Minato; I Gresser; J Holland; A Kadish; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

8.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

9.  Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice.

Authors:  N Minato; B R Bloom; C Jones; J Holland; L M Reid
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

10.  Chédiak-Higashi gene in humans I. Impairment of natural-killer function.

Authors:  T Haliotis; J Roder; M Klein; J Ortaldo; A S Fauci; R B Herberman
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Natural killer cells and autoimmunity.

Authors:  E Grunebaum; E Malatzky-Goshen; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  A decrease in Leu-11a negative lymphocytes in relation to natural killer cell activity in chromate workers.

Authors:  T Tanigawa; S Araki; T Araki; N Minato
Journal:  Br J Ind Med       Date:  1991-03

3.  Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis.

Authors:  M Grazia Cifone; R Giacomelli; G Famularo; R Paolini; C Danese; T Napolitano; A Procopio; A M Perego; A Santoni; G Tonietti
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

4.  Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity.

Authors:  A Takeda; N Minato; S Kano
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

5.  Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.

Authors:  J Masuyama; N Minato; S Kano
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

6.  Sjögren's syndrome in systemic lupus erythematosus and rheumatoid arthritis: immune effector cells in salivary glands.

Authors:  M Malmström; A Seppä; Y T Konttinen; T Helve; S Reitamo
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

7.  Bronchoalveolar lavage in rheumatoid arthritis and secondary Sjögren's syndrome.

Authors:  W Popp; L Ritschka; O Scherak; O Braun; G Kolarz; H Rauscher; H Zwick
Journal:  Lung       Date:  1990       Impact factor: 2.584

8.  Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome.

Authors:  B K Pedersen; P Oxholm; R Manthorpe; V Andersen
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

9.  Effects of immunomodulating treatment on autoimmune sialadenitis in MRL/Mp-lpr/lpr mice.

Authors:  R Jonsson; A Tarkowski; K Bäckman
Journal:  Agents Actions       Date:  1988-12

10.  Natural killer cell activity in workers exposed to benzidine and beta-naphthylamine.

Authors:  T Tanigawa; S Araki; S Ishizu; T Morita; H Okazaki; N Minato
Journal:  Br J Ind Med       Date:  1990-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.